For research use only. Not for therapeutic Use.
NCDM-32B is a potent and selective KDM4 inhibitor that impaires viability and transforming phenotypes of breast cancer[1].
| Catalog Number | I033097 |
| CAS Number | 1239468-48-4 |
| Synonyms | methyl 3-[9-(dimethylamino)nonanoyl-hydroxyamino]propanoate |
| Molecular Formula | C15H30N2O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C15H30N2O4/c1-16(2)12-9-7-5-4-6-8-10-14(18)17(20)13-11-15(19)21-3/h20H,4-13H2,1-3H3 |
| InChIKey | KDYRPQNFCURCQB-UHFFFAOYSA-N |
| SMILES | CN(C)CCCCCCCCC(=O)N(CCC(=O)OC)O |
| Reference | [1]. Ye Q, et al. Genetic alterations of KDM4 subfamily and therapeutic effect of novel demethylase inhibitor in breast cancer. Am J Cancer Res. 2015 Mar 15;5(4):1519-30. |
